Medication info
Ultran Tablets

Ultran Tablets

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mgAcetaminophen›325mg
Manufacturer / importer
KMS Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 100 tablets (10 tablets/PTP*10)
Approval status
Active

MFDS item code 200805520 · Notified 2008.05.16 · Insurance code 654701110

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
KMS Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly Use the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to elderly patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, this medicine does not need to be readministered after dialysis to maintain analgesia. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be taken at intervals of at least 6 hours, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This drug may cause liver damage in individuals who regularly consume more than three alcoholic drinks a day. It is essential to consult with a doctor or pharmacist. If you experience sudden rashes or blisters on the skin, or severe allergic reactions while taking this medication, stop taking it immediately and consult a healthcare professional. The ingredients in this medication may induce seizures, especially if taken in excess of the recommended dose or with certain antidepressants, narcotics, etc., which increases the risk of seizures. Patients with severe respiratory diseases may experience difficulty breathing while taking this medication, so it should be administered in an environment where healthcare professionals can monitor the patient. Taking this medication with alcohol or sedatives can cause severe drowsiness, respiratory depression, and coma, so concurrent use should be avoided. Caution is necessary for patients with head injuries or increased intracranial pressure, as this medication may burden the brain. This medication can cause both psychological and physical dependence, so dependence should be closely monitored during prolonged use. Patients with impaired liver function should consult a doctor before use, as some components of this medication are metabolized in the liver, which may pose a risk of liver damage. Patients with certain genetic metabolic capabilities may experience excessive accumulation of the active ingredient, leading to severe respiratory depression, so special attention is required. Children under 12 years of age and adolescents under 18 who have undergone tonsillectomy or adenoidectomy should not take this medication, and some adolescents are also advised to avoid it. This medication may cause sleep apnea and hypoxia; therefore, symptoms should be continuously monitored during use, and dosage adjustment or discontinuation may be considered as necessary. Hyponatremia may occur while taking this medication, so especially elderly patients or those at risk for hyponatremia should periodically check their serum sodium levels. Individuals with allergic reactions to any component of this medication, those with central nervous system drug overdose, severe respiratory depression, or head injuries should not take this medication. Women who are pregnant or may become pregnant should carefully consider the effects on the fetus before administration, and nursing mothers should avoid use for safety. Drowsiness or dizziness may occur while taking this medication, so caution is needed when driving or operating machinery. In cases of overdose, severe respiratory depression, seizures, and liver damage may occur, so do not exceed the recommended dosage, and if overdose is suspected, seek emergency medical assistance immediately. This medication interacts with various drugs; therefore, if you are taking other medications, be sure to inform and consult a doctor or pharmacist before use.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, appetite loss, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, disorientation, spatial disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremor, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, elevated liver enzymes, generalized pruritus, night sweats, urinary disturbances, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, impact on unstable emotions, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, hyponatremia, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, confusion, tension, worsening migraine, involuntary muscle contractions, dyspnea, asthma, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, renal function abnormalities, oliguria, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, decreased platelets, arrhythmia, exacerbation of hypertension, aortic stenosis, hemorrhage, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, vertigo, confusion, dyspnea, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, dyspepsia, disorientation, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, hemorrhage, paralytic ileus, renal function abnormalities, increased salivation

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air exposure, ideally in a temperature range of 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness over time.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 100 tablets (10 tablets/PTP*10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.